HER2 Ile655Val polymorphism is negatively associated with breast cancer susceptibility.
Felipe Campos de AlmeidaBruna Karina Banin HirataCarolina Batista ArizaRoberta Losi GuembarovskiKaren Brajão de OliveiraKaren Mayumi SuzukiAlda Losi GuembarovskiJulie Massayo Maeda OdaGlauco Akelinghton Freire VitielloMaria Angelica Ehara WatanabePublished in: Journal of clinical laboratory analysis (2018)
Although this polymorphism did not demonstrate potential as a prognostic marker, it may be a suitable susceptibility marker for BC.
Keyphrases